45 results
8-K/A
EX-99.3
KA
Kineta Inc
3 Feb 21
Other Events
4:59pm
, a manufacturer may need to recall a product from the market. Any agency or judicial enforcement action could have a material adverse effect on Yumanity … , manufacturer, or holder of an approved NDA, including, among other things, recall or withdrawal of the product from the market.
Discovery of previously
8-K
EX-99.2
KA
Kineta Inc
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
)
Common stock options
Unvested restricted stock subject to repurchase
Warrants to purchase common stock
Vested restricted stock subject to recall
10-Q
2016 Q1
KA
Kineta Inc
13 May 16
Quarterly report
12:00am
may impose restrictions relative to that product or the manufacturing facility, including requiring recall or withdrawal of the product from the market … or supplements to an NDA submitted by us; or
recall and/or seize product.
Any government investigation of alleged violations of law could require us to expend
10-K
6gb2 e1ltd823z2b
30 Mar 16
Annual report
12:00am
8-K
EX-99.5
1lss8 y31
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm